Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES DR. REDDYS LAB ZYDUS LIFESCIENCES/
DR. REDDYS LAB
 
P/E (TTM) x 34.2 19.7 173.7% View Chart
P/BV x 5.8 4.4 130.1% View Chart
Dividend Yield % 0.6 0.6 91.8%  

Financials

 ZYDUS LIFESCIENCES   DR. REDDYS LAB
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-23
DR. REDDYS LAB
Mar-23
ZYDUS LIFESCIENCES/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs4954,656 10.6%   
Low Rs3193,788 8.4%   
Sales per share (Unadj.) Rs170.31,481.4 11.5%  
Earnings per share (Unadj.) Rs19.8270.7 7.3%  
Cash flow per share (Unadj.) Rs26.9345.7 7.8%  
Dividends per share (Unadj.) Rs6.0040.00 15.0%  
Avg Dividend yield %1.50.9 155.5%  
Book value per share (Unadj.) Rs173.01,389.6 12.5%  
Shares outstanding (eoy) m1,012.20166.53 607.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.42.8 83.9%   
Avg P/E ratio x20.615.6 132.0%  
P/CF ratio (eoy) x15.112.2 123.9%  
Price / Book Value ratio x2.43.0 77.4%  
Dividend payout %30.314.8 205.3%   
Avg Mkt Cap Rs m412,144703,039 58.6%   
No. of employees `000NANA-   
Total wages/salary Rs m24,56446,466 52.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m172,374246,697 69.9%  
Other income Rs m4,74610,555 45.0%   
Total revenues Rs m177,120257,252 68.9%   
Gross profit Rs m29,67763,860 46.5%  
Depreciation Rs m7,22712,502 57.8%   
Interest Rs m1,2991,428 91.0%   
Profit before tax Rs m25,89760,485 42.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,87815,412 38.1%   
Profit after tax Rs m20,01945,073 44.4%  
Gross profit margin %17.225.9 66.5%  
Effective tax rate %22.725.5 89.1%   
Net profit margin %11.618.3 63.6%  
BALANCE SHEET DATA
Current assets Rs m100,082203,161 49.3%   
Current liabilities Rs m55,26785,721 64.5%   
Net working cap to sales %26.047.6 54.6%  
Current ratio x1.82.4 76.4%  
Inventory Days Days5079 63.5%  
Debtors Days Days94107 87.2%  
Net fixed assets Rs m144,776112,638 128.5%   
Share capital Rs m1,012833 121.5%   
"Free" reserves Rs m174,146230,571 75.5%   
Net worth Rs m175,158231,404 75.7%   
Long term debt Rs m01,278 0.0%   
Total assets Rs m244,940315,799 77.6%  
Interest coverage x20.943.4 48.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.70.8 90.1%   
Return on assets %8.714.7 59.1%  
Return on equity %11.419.5 58.7%  
Return on capital %15.526.6 58.4%  
Exports to sales %39.252.2 75.1%   
Imports to sales %11.916.8 70.9%   
Exports (fob) Rs m67,577128,803 52.5%   
Imports (cif) Rs m20,54441,484 49.5%   
Fx inflow Rs m67,577128,803 52.5%   
Fx outflow Rs m20,54441,484 49.5%   
Net fx Rs m47,03387,319 53.9%   
CASH FLOW
From Operations Rs m26,88858,875 45.7%  
From Investments Rs m11,712-41,373 -28.3%  
From Financial Activity Rs m-44,004-26,861 163.8%  
Net Cashflow Rs m-5,338-9,073 58.8%  

Share Holding

Indian Promoters % 75.0 26.7 281.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 18.0 47.3 38.1%  
FIIs % 5.0 28.6 17.4%  
ADR/GDR % 0.0 15.3 -  
Free float % 25.0 58.0 43.1%  
Shareholders   306,495 257,794 118.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    MANKIND PHARMA    SUPRIYA LIFESCIENCE     


More on Cadila Healthcare vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs Dr. Reddys Share Price Performance

Period Cadila Healthcare Dr. Reddys S&P BSE HEALTHCARE
1-Day 0.57% 1.78% 1.18%
1-Month 7.77% -4.23% -0.75%
1-Year 107.52% 35.93% 61.82%
3-Year CAGR 32.30% 10.85% 18.16%
5-Year CAGR 24.52% 17.77% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 30.3%.

Dr. Reddys paid Rs 40.0, and its dividend payout ratio stood at 14.8%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.